GRAIL, Inc. Share-based Payment Arrangement, Expense, Tax Benefit
GRAIL, Inc. (GRAL) reported Share-based Payment Arrangement, Expense, Tax Benefit of $13.71 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-03-12
- GRAIL, Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-12-31 was $7.78M, a 136.24% increase year-over-year.
- GRAIL, Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-09-30 was $637.00K, a 84.94% decline year-over-year.
- GRAIL, Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-06-30 was $900.00K, a 85.71% decline year-over-year.
- GRAIL, Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-03-31 was $4.39M, a 37.83% decline year-over-year.
- GRAIL, Inc. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $13.71M, a 34.38% decline from fiscal 2024.
- GRAIL, Inc. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $20.89M, a 10.94% decline from fiscal 2023.
- GRAIL, Inc. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $23.45M, a 29.97% increase from fiscal 2023.
- GRAIL, Inc. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $18.05M.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|---|---|---|
| 2025-12-31 | $7.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $8.41M derived: sum of 2 quarters · filed 2026-03-12 | $9.31M derived: sum of 3 quarters · filed 2026-03-12 | $13.71M 10-K · filed 2026-03-12 |
| 2025-09-30 | $637.00K 10-Q · filed 2025-11-13 | $1.54M derived: sum of 2 quarters · filed 2025-11-13 | $5.93M 10-Q · filed 2025-11-13 | $9.22M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $900.00K 10-Q · filed 2025-08-13 | $5.29M 10-Q · filed 2025-08-13 | $8.59M derived: sum of 3 quarters · filed 2026-03-12 | $12.82M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $4.39M 10-Q · filed 2025-05-14 | $7.69M derived: sum of 2 quarters · filed 2026-03-12 | $11.92M derived: sum of 3 quarters · filed 2026-03-12 | $18.22M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $7.52M derived: sum of 2 quarters · filed 2026-03-12 | $13.82M derived: sum of 3 quarters · filed 2026-03-12 | $20.89M 10-K · filed 2026-03-12 |
| 2024-09-30 | $4.23M 10-Q · filed 2025-11-13 | $10.53M derived: sum of 2 quarters · filed 2025-11-13 | $17.60M 10-Q · filed 2025-11-13 | $23.59M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | $6.30M 10-Q · filed 2025-08-13 | $13.37M 10-Q · filed 2025-08-13 | $19.36M derived: sum of 3 quarters · filed 2026-03-12 | $25.47M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $7.07M 10-Q · filed 2025-05-14 | $13.06M derived: sum of 2 quarters · filed 2026-03-12 | $19.17M derived: sum of 3 quarters · filed 2026-03-12 | $25.33M derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $12.10M derived: sum of 2 quarters · filed 2026-03-12 | $18.27M derived: sum of 3 quarters · filed 2026-03-12 | $23.45M 10-K · filed 2025-03-05 |
| 2023-09-30 | $6.11M 10-Q · filed 2024-11-13 | $12.27M derived: sum of 2 quarters · filed 2024-11-13 | $17.46M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $6.16M 10-Q · filed 2024-08-13 | $11.35M 10-Q · filed 2024-08-13 | ||
| 2023-01-01 | $18.05M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |